205 related articles for article (PubMed ID: 26110816)
1. Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy.
Cipolletta E; Rusciano MR; Maione AS; Santulli G; Sorriento D; Del Giudice C; Ciccarelli M; Franco A; Crola C; Campiglia P; Sala M; Gomez-Monterrey I; De Luca N; Trimarco B; Iaccarino G; Illario M
PLoS One; 2015; 10(6):e0130477. PubMed ID: 26110816
[TBL] [Abstract][Full Text] [Related]
2. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
[TBL] [Abstract][Full Text] [Related]
3. Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway.
Qian D; Tian J; Wang S; Shan X; Zhao P; Chen H; Xu M; Guo W; Zhang C; Lu R
BMC Complement Med Ther; 2022 Apr; 22(1):115. PubMed ID: 35468773
[TBL] [Abstract][Full Text] [Related]
4. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology.
Fischer TH; Herting J; Tirilomis T; Renner A; Neef S; Toischer K; Ellenberger D; Förster A; Schmitto JD; Gummert J; Schöndube FA; Hasenfuss G; Maier LS; Sossalla S
Circulation; 2013 Aug; 128(9):970-81. PubMed ID: 23877259
[TBL] [Abstract][Full Text] [Related]
5. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
6. CaMKII exacerbates heart failure progression by activating class I HDACs.
Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
[TBL] [Abstract][Full Text] [Related]
7. Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1.
Carrasco L; Cea P; Rocco P; Peña-Oyarzún D; Rivera-Mejias P; Sotomayor-Flores C; Quiroga C; Criollo A; Ibarra C; Chiong M; Lavandero S
J Cell Biochem; 2014 Apr; 115(4):712-20. PubMed ID: 24243530
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
9. Ca2+/calmodulin-dependent protein kinase IIdelta orchestrates G-protein-coupled receptor and electric field stimulation-induced cardiomyocyte hypertrophy.
Zhang W; Qi F; Chen DQ; Xiao WY; Wang J; Zhu WZ
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):795-802. PubMed ID: 20374261
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of calmodulin and Ca
Wang S; Li J; Liu Y; Zhang J; Zheng X; Sun X; Lei S; Kang Z; Chen X; Lei M; Hu H; Zeng X; Hao L
Biochem Biophys Res Commun; 2020 Jun; 526(4):960-966. PubMed ID: 32303334
[TBL] [Abstract][Full Text] [Related]
11. Neuronal calcium sensor-1 promotes immature heart function and hypertrophy by enhancing Ca2+ signals.
Nakamura TY; Jeromin A; Mikoshiba K; Wakabayashi S
Circ Res; 2011 Aug; 109(5):512-23. PubMed ID: 21737792
[TBL] [Abstract][Full Text] [Related]
12. Sustained increased CaMKII phosphorylation is involved in the impaired regression of isoproterenol-induced cardiac hypertrophy in rats.
Li J; Gao Q; Wang S; Kang Z; Li Z; Lei S; Sun X; Zhao M; Chen X; Jiao G; Hu H; Hao L
J Pharmacol Sci; 2020 Sep; 144(1):30-42. PubMed ID: 32665128
[TBL] [Abstract][Full Text] [Related]
13. Nuclear Ca2+/calmodulin-dependent protein kinase II in the murine heart.
Li B; Dedman JR; Kaetzel MA
Biochim Biophys Acta; 2006 Nov; 1763(11):1275-81. PubMed ID: 17069901
[TBL] [Abstract][Full Text] [Related]
14. MiR-625-5p Inhibits Cardiac Hypertrophy Through Targeting STAT3 and CaMKII.
Cai K; Chen H
Hum Gene Ther Clin Dev; 2019 Dec; 30(4):182-191. PubMed ID: 31617427
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CaM-CaMKII-ERK in bisphenol A-induced Sertoli cell apoptosis.
Qian W; Zhu J; Mao C; Liu J; Wang Y; Wang Q; Liu Y; Gao R; Xiao H; Wang J
Toxicology; 2014 Oct; 324():27-34. PubMed ID: 24905940
[TBL] [Abstract][Full Text] [Related]
16. Kv4.3 expression abrogates and reverses norepinephrine-induced myocyte hypertrophy by CaMKII inhibition.
Wang Y; Keskanokwong T; Cheng J
J Mol Cell Cardiol; 2019 Jan; 126():77-85. PubMed ID: 30462989
[TBL] [Abstract][Full Text] [Related]
17. The combined inhibition of the CaMKIIδ and calcineurin signaling cascade attenuates IGF-IIR-induced cardiac hypertrophy.
Chen CH; Lin JW; Huang CY; Yeh YL; Shen CY; Badrealam KF; Ho TJ; Padma VV; Kuo WW; Huang CY
J Cell Physiol; 2020 Apr; 235(4):3539-3547. PubMed ID: 31584202
[TBL] [Abstract][Full Text] [Related]
18. Decorin Induces Cardiac Hypertrophy by Regulating the CaMKII/MEF-2 Signaling Pathway In Vivo.
Yang Y; Yu WW; Yan W; Xia Q
Curr Med Sci; 2021 Oct; 41(5):857-862. PubMed ID: 34643879
[TBL] [Abstract][Full Text] [Related]
19. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
20. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
